Table 2.
Detailed CKD-related parameters
| Characteristic | All (n=14) | Reference Rangesa |
|---|---|---|
| Diagnosis | ||
| ADPKD | 10 | |
| Hypertensive | 3 | |
| Monokidney | 1 | |
| Plasma sodium, mmol/L | 141±1.7 | 135–145 |
| Plasma potassium, mmol/L | 4.2±0.43 | 3.5–5.0 |
| Plasma phosphate, mmol/L | 1.0±0.11 | 0.9–1.5 |
| Plasma PTH, pmol/L | 7.5 [5.4–8.3] | 0.6–6.7 |
| Plasma urea, mmol/L | 11.2 [8–17] | 2.5–6.4 |
| Plasma uric acid, mmol/L | 0.42±0.06 | Men: 0.20–0.42 Women: 0.12–0.34 |
| Plasma albumin, g/L | 43±2.4 | 35–55 |
| Plasma venous HCO3−, mmol/L | 24.7±2.6 | 21–27 |
| Plasma calcium, mmol/L | 2.5±0.11 | 2.10–2.55 |
| Medication use | N/A | |
| Statins | 2 | |
| Antihypertensive | 12 | |
| ACI or ARB | 9 | |
| Diuretic | 3 | |
| β Blocker/calcium antagonist | 3 |
Values are n, mean±SD, or median [interquartile range] for skewed data. ADPKD, adult dominant polycystic kidney disease; PTH, parathyroid hormone; HCO3−, bicarbonate; N/A, not applicable; ACI, angiotensin-converting-enzyme inhibitor; ARB, Angiotensin II receptor antagonists.
a
Reference ranges are derived from reference values clinical chemistry (referentiewaarden klinische chemie, www.farmacotherapeutischkompas.nl).